Thrivent Financial for Lutherans
ISEE

Thrivent Financial for Lutherans’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-203,358
Closed -$744K – 2089
2017
Q1 		$744K Buy
+203,358
New +$859K ﹤0.01% 1331

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Thrivent Financial for Lutherans's ISEE Position: Q2 2017 in Review

Thrivent Financial for Lutherans sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 203,358 shares — an estimated $744K sold.

Thrivent Financial for Lutherans first reported a position in ISEE in Q1 2017 and held it in 1 quarter. The position peaked at $744K in Q1 2017. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • Thrivent Financial for Lutherans reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 203,358 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $744K.
  • Thrivent Financial for Lutherans first reported a position in IVERIC bio, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's IVERIC bio, Inc. Common Stock position peaked at $744K in Q1 2017.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2017, filed 11 Aug 2017.